DCMSHRIRAM - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.7
| Stock Code | DCMSHRIRAM | Market Cap | 17,397 Cr. | Current Price | 1,114 ₹ | High / Low | 1,502 ₹ |
| Stock P/E | 20.3 | Book Value | 494 ₹ | Dividend Yield | 0.81 % | ROCE | 11.5 % |
| ROE | 11.6 % | Face Value | 2.00 ₹ | DMA 50 | 1,152 ₹ | DMA 200 | 1,162 ₹ |
| Chg in FII Hold | -0.01 % | Chg in DII Hold | 0.24 % | PAT Qtr | 346 Cr. | PAT Prev Qtr | 237 Cr. |
| RSI | 40.6 | MACD | -15.3 | Volume | 39,216 | Avg Vol 1Wk | 33,659 |
| Low price | 945 ₹ | High price | 1,502 ₹ | PEG Ratio | -6.96 | Debt to equity | 0.37 |
| 52w Index | 30.3 % | Qtr Profit Var | 98.1 % | EPS | 53.7 ₹ | Industry PE | 19.8 |
📊 Financial Overview: DCM Shriram (DCMSHRIRAM) shows moderate fundamentals. ROE is 11.6% and ROCE is 11.5%, reflecting average efficiency. Debt-to-equity is 0.37, indicating manageable leverage. Dividend yield is modest at 0.81%. Quarterly PAT rose sharply from ₹237 Cr. to ₹346 Cr. (98.1% variation), showing strong earnings momentum despite overall volatility.
💹 Valuation Indicators: Current P/E of 20.3 is slightly above the industry average of 19.8, suggesting fair valuation. P/B ratio is ~2.3 (1114/494), which is reasonable. PEG ratio is negative (-6.96), signaling weak growth prospects relative to valuation. Intrinsic value appears close to current price, implying cautious accumulation.
🏢 Business Model & Advantage: DCM Shriram operates in chemicals, fertilizers, and agribusiness. Its competitive advantage lies in diversified operations, established distribution, and strong presence in rural markets. However, cyclical demand and commodity price volatility impact profitability.
📈 Entry Zone: A favorable entry zone lies between ₹1,050–1,100, closer to intrinsic value and support levels. Current price (₹1,114) is near this zone, making staggered accumulation reasonable.
🔒 Long-Term Holding Guidance: DCM Shriram is a stable long-term play due to its diversified portfolio and industry relevance. While valuations are fair, modest return ratios and cyclical risks warrant cautious holding. Long-term investors can hold selectively, monitoring commodity cycles and earnings consistency.
Positive
- 🌟 PAT growth from ₹237 Cr. to ₹346 Cr. (98.1%)
- 🌟 Reasonable P/E (20.3) near industry average
- 🌟 Diversified operations across chemicals and agribusiness
- 🌟 DII holdings increased (+0.24%)
Limitation
- ⚠️ Low ROE (11.6%) and ROCE (11.5%)
- ⚠️ PEG ratio negative (-6.96)
- ⚠️ Dividend yield modest (0.81%)
- ⚠️ Commodity cycle exposure impacts margins
Company Negative News
- 📉 FII holdings reduced (-0.01%)
- 📉 Profitability remains cyclical and volatile
Company Positive News
- 📈 Strong quarterly PAT improvement
- 📈 DII holdings increased (+0.24%)
Industry
- 🏦 Industry P/E at 19.8 reflects fair valuations
- 🏦 Agrochemical and fertilizer demand supported by rural growth
Conclusion
✅ DCM Shriram has diversified operations and strong quarterly earnings growth, but modest return ratios and cyclical risks limit attractiveness. A better entry zone lies between ₹1,050–1,100. Long-term investors can hold cautiously, leveraging its industry relevance while monitoring commodity cycles and profitability trends.
Would you like me to also prepare a commodity cycle outlook to assess how raw material price movements could affect its long-term profitability?